Join the Rasuvo group to help and get support from people like you.
Rasuvo News
Benefits of Long-Term Routine Lab Drug Toxicity Monitoring Unclear in RA
TUESDAY, Aug. 26, 2025 – For patients with rheumatoid arthritis (RA) using disease-modifying antirheumatic drugs (DMARDs), long-term routine laboratory toxicity monitoring (lt-RLTM) indicates that...
Methotrexate Noninferior to Prednisone in Pulmonary Sarcoidosis
TUESDAY, May 20, 2025 – For patients with pulmonary sarcoidosis, methotrexate is noninferior to prednisone with regard to the change from baseline to week 24 in the percentage of the predicted...
Glucarpidase Improves Outcomes in Patients With Methotrexate-Induced Kidney Toxicity
THURSDAY, Jan. 16, 2025 – For patients with methotrexate (MTX)-acute kidney injury (AKI), glucarpidase is associated with improved renal and extrarenal outcomes, according to a study published...
FDA Medwatch Alert: Injectable Products by Mylan: Recall - Presence of Particulate Matter
including certain lots of: Gemcitabine for Injection Carboplatin Injection Methotrexate Injection Cytarabine Injection See the press release for a listing of the product strength, NDC, and lot...
Further information
Related condition support groups
Rheumatoid Arthritis, Psoriasis